Target intelligence / Profile preview

Intestinal disaccharidases and related brush-border digestive enzymes

Molecular classification
Enzyme, Hydrolase, Glycosidase
01

Overview

Intestinal disaccharidases and related brush-border digestive enzymes are a specialized group of hydrolases anchored to the microvilli of enterocytes in the small intestine. This group primarily includes sucrase-isomaltase (SI), maltase-glucoamylase (MGAM), lactase (LCT), and trehalase (TREH), which catalyze the final step of carbohydrate digestion by hydrolyzing disaccharides and oligosaccharides into monosaccharides like glucose, fructose, and galactose (StatPearls, 2023; UniProt, 2024). These enzymes are essential for nutrient absorption and systemic energy homeostasis. In the context of type 2 diabetes and obesity, they serve as therapeutic targets for alpha-glucosidase inhibitors, which delay glucose absorption to manage postprandial hyperglycemia (PubMed, 2022). Deficiencies in these enzymes, whether congenital or acquired, lead to malabsorption disorders such as lactose intolerance and congenital sucrase-isomaltase deficiency (CSID), resulting in osmotic diarrhea and flatulence (NIH, 2023). Pharmacological management involves either the inhibition of these enzymes to control metabolic disorders or enzyme replacement therapy to restore digestive function in deficient patients.

Other names
Intestinal brush-border enzymesIntestinal glycosidasesAlpha-glucosidasesIntestinal hydrolasesDisaccharidases
02

Mechanism of action

Competitive inhibition of alpha-glucosidase enzymes (sucrase, maltase, glucoamylase) to delay carbohydrate digestion and glucose absorption, or exogenous enzyme replacement to restore hydrolytic activity in deficiency states (StatPearls, 2023).

03

Biological functions

Carbohydrate metabolismDigestionNutrient absorption
04

Disease associations

Diabetes mellitus type 2ObesityCongenital sucrase-isomaltase deficiencyLactose intoleranceMalabsorption syndrome
05

Safety considerations

Gastrointestinal distress (flatulence, diarrhea, bloating)MalabsorptionElevated liver transaminasesHypoglycemia when combined with other antidiabetics
06

Interacting drugs

Acarbose

4 more in the full profile.

07

Biomarkers

Postprandial blood glucoseHbA1cHydrogen breath testIntestinal disaccharidase activity assayStool pH

Beyond the preview

Go deeper on Intestinal disaccharidases and related brush-border digestive enzymes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal disaccharidases and related brush-border digestive enzymes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call